138 related articles for article (PubMed ID: 9023649)
1. The tolerance and pharmacokinetics of clinafloxacin (CI-960) in healthy subjects.
Bron NJ; Dorr MB; Mant TG; Webb CL; Vassos AB
J Antimicrob Chemother; 1996 Dec; 38(6):1023-9. PubMed ID: 9023649
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and inflammatory fluid penetration of clinafloxacin.
Wise R; Jones S; Das I; Andrews JM
Antimicrob Agents Chemother; 1998 Feb; 42(2):428-30. PubMed ID: 9527799
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and tolerance of a new fluoroquinolone antimicrobial drug after single oral doses in healthy volunteers.
Tanaka M; Tamura K; Atarashi S; Kubo Y; Oliver SD; Bentley M; Hakusui H
Xenobiotica; 1995 Nov; 25(10):1119-25. PubMed ID: 8578768
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of clinafloxacin after single and multiple doses.
Randinitis EJ; Brodfuehrer JI; Eiseman I; Vassos AB
Antimicrob Agents Chemother; 2001 Sep; 45(9):2529-35. PubMed ID: 11502525
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and tolerance of DU-6859a, a new fluoroquinolone, after single and multiple oral doses in healthy volunteers.
Nakashima M; Uematsu T; Kosuge K; Umemura K; Hakusui H; Tanaka M
Antimicrob Agents Chemother; 1995 Jan; 39(1):170-4. PubMed ID: 7695301
[TBL] [Abstract][Full Text] [Related]
6. Safety, tolerability and pharmacokinetics of the new long-acting quinolone DW-116 after single and multiple dosing in healthy subjects.
Meyerhoff C; Dilger C; Yoon SJ; Chung YH; Lee DK; Lee CW; Ryu JM; Choi MS; Pabst G; Reh C
J Antimicrob Chemother; 1998 Sep; 42(3):349-61. PubMed ID: 9786475
[TBL] [Abstract][Full Text] [Related]
7. Multiple-dose pharmacokinetics and safety of rufloxacin in normal volunteers.
Kisicki JC; Griess RS; Ott CL; Cohen GM; McCormack RJ; Troetel WM; Imbimbo BP
Antimicrob Agents Chemother; 1992 Jun; 36(6):1296-301. PubMed ID: 1329618
[TBL] [Abstract][Full Text] [Related]
8. Clinafloxacin pharmacokinetics in subjects with various degrees of renal function.
Randinitis EJ; Koup JR; Rausch G; Abel R; Bron NJ; Hounslow NJ; Vassos AB; Sedman AJ
Antimicrob Agents Chemother; 2001 Sep; 45(9):2536-42. PubMed ID: 11502526
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of rufloxacin in healthy volunteers after repeated oral doses.
Mattina R; Bonfiglio G; Cocuzza CE; Gulisano G; Cesana M; Imbimbo BP
Chemotherapy; 1991; 37(6):389-97. PubMed ID: 1662127
[TBL] [Abstract][Full Text] [Related]
10. Multiple-dose pharmacokinetics and safety of trovafloxacin in healthy volunteers.
Teng R; Liston TE; Harris SC
J Antimicrob Chemother; 1996 May; 37(5):955-63. PubMed ID: 8737145
[TBL] [Abstract][Full Text] [Related]
11. Single- and multiple-dose pharmacokinetics of AM-1155, a new 6-fluoro-8-methoxy quinolone, in humans.
Nakashima M; Uematsu T; Kosuge K; Kusajima H; Ooie T; Masuda Y; Ishida R; Uchida H
Antimicrob Agents Chemother; 1995 Dec; 39(12):2635-40. PubMed ID: 8592993
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of temafloxacin in humans after multiple oral doses.
Granneman GR; Carpentier P; Morrison PJ; Pernet AG
Antimicrob Agents Chemother; 1992 Feb; 36(2):378-86. PubMed ID: 1318680
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of clinafloxacin enantiomers in humans.
Humphrey GH; Shapiro MA; Randinitis EJ; Guttendorf RJ; Brodfuehrer JI
J Clin Pharmacol; 1999 Nov; 39(11):1143-50. PubMed ID: 10579144
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and safety of single oral doses of lomefloxacin.
Morse IS
Biopharm Drug Dispos; 1990; 11(6):543-51. PubMed ID: 2207304
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of grepafloxacin after oral administration of single and repeat doses in healthy young males.
Efthymiopoulos C; Bramer SL; Maroli A
Clin Pharmacokinet; 1997; 33 Suppl 1():1-8. PubMed ID: 9433650
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of grepafloxacin.
Efthymiopoulos C
J Antimicrob Chemother; 1997 Dec; 40 Suppl A():35-43. PubMed ID: 9484872
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics and tolerance of lomefloxacin after sequentially increasing oral doses.
Morrison PJ; Mant TG; Norman GT; Robinson J; Kunka RL
Antimicrob Agents Chemother; 1988 Oct; 32(10):1503-7. PubMed ID: 3214495
[TBL] [Abstract][Full Text] [Related]
18. Multiple-dose pharmacokinetics and tolerability of gemifloxacin administered orally to healthy volunteers.
Allen A; Bygate E; Vousden M; Oliver S; Johnson M; Ward C; Cheon A; Choo YS; Kim I
Antimicrob Agents Chemother; 2001 Feb; 45(2):540-5. PubMed ID: 11158752
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics, safety, and tolerability of ascending single doses of moxifloxacin, a new 8-methoxy quinolone, administered to healthy subjects.
Stass H; Dalhoff A; Kubitza D; Schühly U
Antimicrob Agents Chemother; 1998 Aug; 42(8):2060-5. PubMed ID: 9687407
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of sparfloxacin in healthy volunteers and patients: a review.
Montay G
J Antimicrob Chemother; 1996 May; 37 Suppl A():27-39. PubMed ID: 8737123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
